Cerebras' inference opportunity can support substantial long-term upside if installed capacity grows from 60MW to 3.2GW by 2031 and OpenAI renews after 2028. The risk-adjusted model puts 2031 value at $485-$700 per share while assuming rivals narrow its speed premium and customers and partners fund most capex. If those assumptions fail, capex, dilution and valuation risk rise. x.com 

Cerebras Systems offers the fastest AI inference chip available, a single wafer-sized processor with the model's memory on the chip, running inference several times faster than GPU systems. It has a $25.4B backlog, about 30x this year's revenue, partnerships with OpenAI, AMD and AWS, and no exposure to rising HBM prices. Concerns: a 14.2% GAAP gross margin, about $600M of free cash flow burned in the first half, roughly 80% of backlog tied to OpenAI, and about 171M shares unlocking in November. … Show more

Cerebras is likely heading lower after terrible earnings, with share unlocks about to add supply. Its valuation was so stretched that it couldn't afford a miss, and it apparently missed; a lot of hope was already built into the price. It could trade around $150 soon. x.com  x.com  x.com  x.com 

Cerebras is a speculative, high-risk, high-reward bet on faster inference that could make its $44B market cap a multi-bagger if it works. Putting the whole processor and memory on one wafer wins on speed, not cheaper memory, since on-chip SRAM costs more per bit than HBM; Nvidia is answering via Groq. G42 and MBZUAI were 86% of 2025 revenue, but the ramp ahead is tied to OpenAI. The $160s level has held as support four times since the IPO. Size it to one's capital-preservation goals. x.com 

Cerebras has significant multi-year upside because its wafer-scale chip does fast inference better than anything else, and latency-sensitive inference is growing about 2x faster than training. Holding the whole model in on-chip SRAM gives up to 15x faster inference than leading GPU solutions; it took OpenAI's fast-inference business from NVIDIA, and management has already raised prices on excess demand. A $20B take-or-pay OpenAI deal for 750MW through 2028 anchors $24.6B of RPO. x.com  x.com 

Cerebras' COO selling all his sellable Class A shares is not a good look for shareholders, even though the sale was scheduled under a plan. He still holds Class B shares he cannot sell during the lockup, which runs until November; @athuinvests notes much of the sale was old $0.98 options and leftover vested stock, making selling after the lockup the real test. x.com  x.com  x.com  x.com  x.com 

Cerebras looks cheap if it can grow revenue tenfold over three years, though expensive on 2026 numbers. Its 15% after-hours drop looks unwarranted after it raised full-year guidance and gross margins, and management expects gross margins to rise from 40% to 60%, implying EBITDA margins of 40% or more. At about $50 billion with almost $9 billion of cash, $10 billion of 2029 revenue could make it a 3-bagger in three years, but it is a riskier story with serious customer concentration. x.com  x.com  … Show more

Cerebras' Supernova event turned its wafer-scale engine into rack-scale decode infrastructure, so the test now is CS-4 shipments and the pace of its 600MW buildout. CS-4, with three WSE-3 Turbo chips, ships in Q3 2026, a next generation follows in 2027, and CEO Andrew Feldman reaffirmed 600MW of compute by end-2027. BNP Paribas sees the OpenAI, AWS and AMD links as proof of rising decode demand, and UBS kept Buy at $330. Mizuho floated Meta as a major customer in Q4, which is unconfirmed. x.com  … Show more

Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.com 

Cerebras Systems builds AI chips that run up to 15x faster than leading GPU solutions, and it swung from a $481M net loss in 2024 to $237M net profit in 2025 as revenue rose 76% to $510M. Its IPO was 20x oversubscribed and priced at $185, above a raised range, and OpenAI and AWS have multi-year contracts. A small position suits those with AI-infrastructure conviction and real risk tolerance; cautious investors should wait for one or two earnings reports, as IPO 12-month returns are weak. x.com